Department of Parasitology, Institute of Tropical Medicine, Nationalestraat 155, B-2000 Antwerp, Belgium.
J Clin Microbiol. 2010 Aug;48(8):2836-9. doi: 10.1128/JCM.00456-10. Epub 2010 Jun 23.
The accuracy of diagnostic tests for HIV in patients with tropical infections is poorly documented. Human African trypanosomiasis (HAT) is characterized by a polyclonal B-cell activation, constituting a risk for false-positive reactions to diagnostic tests, including HIV tests. A retrospective study of the accuracy of HIV diagnostic tests was performed with 360 human African HAT patients infected with Trypanosoma brucei gambiense before treatment and 163 T. b. gambiense-infected patients 2 years after successful treatment in Mbuji Mayi, East Kasai, Democratic Republic of the Congo. The sensitivities, specificities, and positive predictive values (PPVs) of individual tests and algorithms consisting of 3 rapid tests were determined. The sensitivity of all tests was 100% (11/11). The low specificity (96.3%, 335/348) and PPV (45.8%, 11/24) of a classical seroconfirmation strategy (Vironostika enzyme-linked immunosorbent assay [ELISA] followed by line immunoassay) complicated the determination of HIV status, which had to be determined by PCR. The specificities of the rapid diagnostic tests were 39.1% for Determine (136/348); 85.3 to 92.8% (297/348 to 323/348) for Vikia, ImmunoFlow, DoubleCheck, and Bioline; and 96.6 to 98.3% (336/348 to 342/348) for Uni-Gold, OraQuick, and Stat-Pak. The specificity of Vironostika was 67.5% (235/348). PPVs ranged between 4.9 and 64.7%. Combining 3 different rapid tests resulted in specificities of 98.3 to 100% (342/348 to 348/348) and PPVs of 64.7 to 100% (11/17 to 11/11). For cured HAT patients, specificities were significantly higher for Vironostika, Determine, Uni-Gold, and ImmunoFlow. T. b. gambiense infection decreases the specificities of antibody detection tests for HIV diagnosis. Unless tests have been validated for interference with HAT, HIV diagnosis using classical algorithms in untreated HAT patients should be avoided. Specific, validated combinations of 3 HIV rapid tests can increase specificity.
在患有热带感染的患者中,HIV 诊断检测的准确性记录不佳。人类非洲锥虫病(HAT)的特征是多克隆 B 细胞激活,这构成了诊断检测(包括 HIV 检测)出现假阳性反应的风险。在刚果民主共和国东开赛省姆布吉马伊,对 360 例在治疗前感染布氏冈比亚锥虫的人类非洲锥虫病患者和 163 例在成功治疗 2 年后感染布氏冈比亚锥虫的患者进行了 HIV 诊断检测准确性的回顾性研究。确定了单独检测和由 3 种快速检测组成的算法的灵敏度、特异性和阳性预测值(PPV)。所有检测的灵敏度均为 100%(11/11)。经典的血清确证策略(Vironostika 酶联免疫吸附试验[ELISA]后进行免疫印迹)的低特异性(96.3%,335/348)和阳性预测值(45.8%,11/24)使 HIV 状态的确定变得复杂,必须通过 PCR 来确定。快速诊断检测的特异性分别为:Determine 为 39.1%(136/348);Vikia、ImmunoFlow、DoubleCheck 和 Bioline 为 85.3%至 92.8%(297/348 至 323/348);Uni-Gold、OraQuick 和 Stat-Pak 为 96.6%至 98.3%(336/348 至 342/348)。Vironostika 的特异性为 67.5%(235/348)。PPV 范围为 4.9%至 64.7%。结合 3 种不同的快速检测方法,特异性为 98.3%至 100%(342/348 至 348/348),阳性预测值为 64.7%至 100%(11/17 至 11/11)。对于治愈的 HAT 患者,Vironostika、Determine、Uni-Gold 和 ImmunoFlow 的特异性显著更高。布氏冈比亚锥虫感染降低了 HIV 诊断中抗体检测的特异性。除非针对 HAT 进行了检测干扰验证,否则不应在未经治疗的 HAT 患者中使用经典算法进行 HIV 诊断。3 种 HIV 快速检测的特异性、经过验证的组合可以提高特异性。